BRIC 'not delivering' on promises of high growth

Frost & Sullivan report highlights the difficulties for pharma emerging from the BRIC markets

Sanofi and AstraZeneca form cancer research alliances with non-profits

Will work respectively with Curie Institute in France and Cancer Research UK

Kantar Media and Pointlogic unveil comms planning platform

Will determine most appropriate channel for reaching target audiences

AbbVie: UK patients want better arthritis care

Study from Humira manufacturer concludes that UK doctors need better collaboration with patients

Pay-for-delay deals lead to inflated drug prices says study

Based on analysis of delayed market entry of generic Adderall XR in US

Celgene wins expanded EU approval for cancer drug Revlimid

Approved for use in patients with rare blood disorder

Alexion begins work on new global headquarters

Rare diseases drug company will move to new US site in 2015

Novartis launches European advanced breast cancer campaign

Virgo Health helps create audio/visual installation

J&J acquires oncology candidate in $1bn Aragon buy

ARN-509 is in phase II development for castration resistant prostate cancer

Think positive: the rise of 'smart drugs'

More and more people are turning to nootropics or 'smart drugs' to enhance their cognitive ability. But what do they do, what are the risks and where do the ethical

The future of HTA harmonisation in Europe

The variety and variability of European health technology assessment criteria have created a challenging environment for pharma and a need for much greater harmonisation
Carving an identity through customer-focused innovation

Building pharma brands driven by customer-focused innovation will enable companies to differentiate their products in a crowded marketplace

More features

Men's oesophageal cancer risk "triple that of women"

New data from Cancer Research UK shines slight on 'quiet epidemic'
AstraZeneca picks location for global HQ and research base

Decides on the Cambridge Biomedical Campus in UK
Elotuzumab on track for multiple myeloma

BMS and AbbVie present phase II results at European Haematology Association meeting
New data backs J&J’s ibrutinib efficacy in B cell cancers

Phase II results showcased at European Hematology Association meeting
AstraZeneca and NGM form diabetes/ obesity partnership

Will use MedImmune arm to develop treatments that target gastrointestinal hormones
Jakavi shows long-term survival benefit in myelofibrosis

Trial demonstrates Novartis’ blood cancer drug cut risk of death by half over three years
UK launch for Pfizer's long-acting contraceptive injection Sayana

Becomes first contraceptive of its kind to reach the UK market

More news

Latest appointments

Healthwatch England appoints comms and policy directors

Claire Pimm joins from DH and Marc Bush joins from Scope
Former UK health secretary joins Bupa board

Patricia Hewitt will serve private health firm as non-executive director
Former Novartis president joins Qu Biologics

Robert Pelzer is appointed board member at immunotherapy specialists
ABPI appoints new director of comms

Catherine Meaden was previously head of policy and public affairs at the body
Icon appoints Dr Neil McCullough to senior compliance role

He joins the clinical research organisation from PPD

More appointments

Featured jobs

Head of Commercial Training Strategy (m/ f): On application
Marketing Manager - Pharmaceuticals, Northern UK: Excellent Salary & Benefits
UK Marketing Director: 80,000 to 100,000 per annum
Medical Writer / Editor – LONDON: DOE

Subscribe to our email news alerts

PMHub

Add my company

Litmus MME

LITMUS places the development of strong physician relationships at the centre of every program and has established a new standard ...

Latest intelligence

Building BRICs: pharma's key emerging markets are becoming giants: The BRIC nations – Brazil, Russia, India and China – for so long the leading lights of the emerging markets movement, may soon need to relinquish their 'emerging' tag and become 'giants'...
What IF (Indigenus Forum) Meeting Report: IFs (Indigenus Forums) are a series of invite-only events hosted by Indigenus agencies that bring top thought leaders together to help solve some of our industry’s most pressing challenges. ...
Developing multichannel capability in Pharma: Understanding your customers' needs is only half of the multichannel challenge; you must also have the business capability to deliver on your objectives. Find out how training could give your ...